Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Carcinoma intraepitelial tubárico seroso como hallazgo posquirúrgico de endometriosis y útero miomatoso. Reporte de un caso

Seuous tubal intraepithelial carcinoma as a post-surgical finding of endometriosis and myomatous uterus. A case report.

Ginecol Obstet Mex. 2020; 88 (9): 625-631.

https://doi.org/10.24245/gom.v88i9.4081

Pablo Luque-González,1 Mercedes Requerey-Fernández,1 Zoraida Frías-Sánchez,2 María del Pilar Guadix-Martín,1 Antonio Jiménez-Caraballo,1 Álvaro Gutiérrez-Domingo,3 Manuel Pantoja-Garrido1

1 Unidad de Gestión Clínica de Ginecología y Obstetricia, Hospital Universitario Virgen Macarena, Sevilla, España.
2 Unidad de Gestión Clínica de Ginecología y Patología Mamaria, Hospital Universitario Virgen del Rocío, Sevilla, España.
3 Unidad de Gestión Clínica de Anatomía Patológica, Hospital Universitario Virgen Macarena, Sevilla, España.


Corrrespondencia:

Zoraida Frías Sánchez
fszoraida@gmail.com

Debe citarse como:

Luque-González P, Requerey-Fernández M, Frías-Sánchez Z, Guadix-Martín MP, Jiménez-Caraballo A, Gutiérrez-Domingo A, Pantoja-Garrido M. Carcinoma intraepitelial tubárico seroso como hallazgo posquirúrgico de endometriosis y útero miomatoso. Reporte de un caso. Ginecol Obstet Mex. 2020; 88 (9): 625-631. https://doi.org/10.24245/gom.v88i9.4081

Resumen

ANTECEDENTES: El carcinoma intraepitelial tubárico seroso es una lesión precursora del carcinoma invasivo de las trompas de Falopio que con frecuencia se diagnostica en el contexto de una salpingooforectomía bilateral profiláctica por patología ginecológica benigna.

CASO CLÍNICO: Paciente nulípara, de 51 años, con cuadro clínico de dolor abdominal y elevación de marcadores tumorales CA-125 y CA-19.9, diagnosticada con útero polimiomatoso y sospecha de endometrioma en el ovario derecho. Después de la histerectomía subtotal con anexectomía bilateral, el estudio histológico de la pieza tubárica extirpada reportó focos microscópicos de carcinoma intraepitelial tubárico seroso, sin signos de invasión estromal. Por los hallazgos se solicitaron pruebas de imagen mamarias y el estudio genético de mutación BRCA 1 y 2.

CONCLUSIÓN: La salpingooforectomía bilateral profiláctica es un procedimiento que reduce el riesgo de carcinomas peritoneales, tubáricos y serosos de ovario. Las pacientes con carcinoma intraepitelial tubárico seroso deben tener seguimiento basado en controles ecográficos, pruebas de imagen mamarias, determinación de marcadores tumorales y estudios genéticos, debido a su asociación con mutaciones en los genes BRCA 1 y 2.

PALABRAS CLAVE: Carcinoma intraepitelial tubárico seroso; ovario; dolor abdominal; marcadores tumorales; endometrioma; histerectomía subtotal; mutación de los genes BRCA 1 y 2; protocolos clínicos.

Abstract

BACKGROUND: Serous tubal intraepithelial carcinoma (STIC) is a precursor lesion of invasive high-grade tubal and serous carcinoma of the ovary, frequently diagnosed in the context of prophylactic bilateral salpingoophorectomy for benign gynecological pathology. The objective of this work is to carry out a literature review on the most relevant aspects of the follow-up of this injury, after its incidental diagnosis in gynecological surgery.

CLINICAL CASE: A 51-year-old nulliparous patient who, in the context of a clinical situation of abdominal pain with elevation of tumor markers CA125 and CA19.9, was diagnosed with polymomatous uterus and suspected endometrioma in the right ovary. After a subtotal hysterectomy with bilateral adnexectomy, the histological study of the excised tubal specimen found microscopic foci of STIC without signs of stromal invasion. Given this finding, breast imaging tests and a genetic study of the BRCA 1/2 mutation was requested.

CONCLUSION: Prophylactic bilateral salpingoophorectomy in gynecological surgery is a procedure that can reduce the risk of developing peritoneal, tubal, and serous ovarian carcinomas. Patients diagnosed with STIC should be subsidiaries of follow-up based on ultrasound controls, mammary imaging tests, tumor markers, and genetic studies, due to their association in many cases with mutations in the BRCA 1/2 genes. It is necessary to establish a series of standardized clinical protocols for the management of patients with STIC and to continue advancing our understanding of this pathology and its subsequent evolution to high-grade serous carcinoma.

KEYWORDS: Serous tubal intraepithelial carcinoma; Ovary; Abdominal pain; Tumor markers; Endometrioma; subtotal hysterectomy; BRCA 1/2 mutations; Clinical protocols.

    1. Gutkin DW, et al. Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary. Cancer Biomark. 2019;26(4):471-479. doi: 10.3233/CBM-190528.
    2. Zhang S, et al. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma. Nat Commun. 2019;10(1):5367. doi: 10.1038/s41467-019-13116-2.
    3. Stewart ME, et al. Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers. Gynecol Oncol Rep. 2019; 28: 18-22. doi: 10.1016/j.gore.2019.01.010.
    4. Stanciu PI, et al. Development of peritoneal carcinoma in women diagnosed with serous tubal intraepithelial carcinoma (STIC) following risk-reducing salpingo-oophorectomy (RRSO). J Ovarian Res. 2019; 12: 50. doi: 10.1186/s13048-019-0525-1.
    5. Arora S, et al. Evaluation of SEE-FIM (Sectioning and Extensively Examining the FIMbriated End) protocol in identifying fallopian tube precursor lesions in women with ovarian tumors. J Obstet Gynaecol India. 2019; 69 (2): 153-59. doi: 10.1007/s13224-018-1155-z.
    6. Kaur H, et al. Papillary syncytial metaplasia of fallopian tube endometriosis: a potential pitfall in the diagnosis of serous tubal intraepithelial carcinoma. Arch Pathol Lab Med. 2013; 137 (1): 126-9. doi: 10.5858/arpa.2011-0312-CR.
    7. Seidman JD, et al. High-grade pelvic serous carcinoma within the fallopian tube lumen: real or artifact? Int J Gynecol Pathol. 2019.. doi: 10.1097/PGP.0000000000000649.
    8. Rojo-Novo S, et al. Displasia epitelial tubárica de alto grado tras anexectomía bilateral profiláctica por cáncer de mama, en paciente con mutación en el gen BRCA1. Rev Obstet Ginecolog Venez. 2018; 78 (2): 157-64. doi: 10.4067/s0717-75262018000200182.
    9. Meserve EEK, et al. Frequency of incidental serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: A six-year study. Gynecol Oncol. 2017; 146 (1): 69-73. doi: 10.1016/j.ygyno.2017.04.015.
    10. Gilks CB, et al. Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas. Am J Surg Pathol. 2015; 39 (3): 357-64. doi: 10.1097/pas.0000000000000353.
    11. Samimi G, et al. Population frequency of serous tubal intraepithelial carcinoma (STIC) in clinical practice using SEE-Fim Protocol. JNCI Cancer Spectrum 2018; 2 (4): pky061. doi: 10.1093/jncics/pky061.
    12. Visvanathan K, et al. Fallopian tube lesions in women at high risk for ovarian cancer: a multicenter study. Cancer Prev Res (Phila). 2018; 11 (11): 697-706. doi: 10.1158/1940-6207.
    13. Wong JWH, et al. Completeness of salpingectomy intended for ovarian cancer risk reduction. Gynecol Oncol. 2019; 155 (2): 280-82. doi: 10.1016/j.ygyno.2019.09.005.

Comentarios